Phoenix Biotech Acquisition Corp. (PBAX) Research

Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.

Market snapshot

Symbol
PBAX
Price
$5.85
Day change
+6.75%
Market cap
$36.5M
P/E ratio
-1.75x
52-week range
4.12-12.8
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • A SPAC I Acquisition Corp. (ASCA)
  • Achari Ventures Holdings Corp. I (AVHI)
  • Blue Safari Group Acquisition Corp. (BSGA)
  • ConnectM Technology Solutions, Inc. (CNTM)
  • Gardiner Healthcare Acquisitions Corp. (GDNR)
  • Iron Horse Acquisitions Corp. Common Stock (IROH)
  • Jet.AI Inc. (JTAI)
  • Moringa Acquisition Corp (MACA)

Recent insider activity

  • PHOENIX BIOTECH SPONSOR, LLC — J-Other (82875 shares) on 2021-10-08
  • PHOENIX BIOTECH SPONSOR, LLC — J-Other (36733 shares) on 2021-10-08
  • PHOENIX BIOTECH SPONSOR, LLC — J-Other (18366 shares) on 2021-10-08
  • Ehrlich Christopher B — J-Other (82875 shares) on 2021-10-08
  • Ehrlich Christopher B — J-Other (36733 shares) on 2021-10-08

Open Phoenix Biotech Acquisition Corp. (PBAX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.